Securities code: 688013 securities abbreviation: Touchstone International Medical Science Co.Ltd(688013) Announcement No.: 2022-003 Touchstone International Medical Science Co.Ltd(688013)
Announcement of resolutions of the 19th meeting of the first board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
1、 Meetings of the board of directors
The 19th meeting of the first board of directors of Touchstone International Medical Science Co.Ltd(688013) (hereinafter referred to as “the company”) was held on February 8, 2022 in the company’s conference room by on-site combined with communication voting. The notice of this meeting was sent to all directors in writing and by telephone on February 3, 2022. The meeting was presided over by the chairman, Mr. Chen Wangyu. The convening and convening method of the meeting met the provisions of the company law and the articles of association.
2、 Deliberations of the board meeting
The following proposals were considered and adopted by open ballot at this meeting:
1. Deliberated and passed the proposal on repurchase of company shares by means of centralized bidding transaction
The board of directors received the letter on proposing Touchstone International Medical Science Co.Ltd(688013) repurchase of shares of the company from Mr. Chen Wangyu, chairman of the board of directors, controlling shareholder and one of the actual controllers of the company. The company plans to use its own funds to repurchase shares through centralized bidding transaction. All repurchased shares will be used for employee stock ownership plan or equity incentive. The repurchase price shall not exceed 23.00 yuan / share (inclusive), and the total repurchase funds shall not be less than 50 million yuan (inclusive) and not more than 100 million yuan (inclusive). At the same time, the management of the company is authorized to handle matters related to this share repurchase. According to the articles of association, the share repurchase plan does not need to be submitted to the general meeting of shareholders for deliberation.
Voting results: 7 in favor, 0 abstention, 0 against and 0 withdrawal
The independent directors of the company expressed their explicit consent to the proposal.
For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) published by the company on the same day Announcement of Touchstone International Medical Science Co.Ltd(688013) on the scheme of repurchasing shares of the company by means of centralized bidding transaction (Announcement No.: 2022-004).
It is hereby announced.
Touchstone International Medical Science Co.Ltd(688013) board of directors February 9, 2022
